Keep Going. Everyday there May be Hope
Saundra Rosas muokkasi tätä sivua 3 viikkoa sitten


We're a clinical-stage life sciences company centered on the research and clinical development of anti-inflammatory and painless SPO2 testing anti-fibrotic therapies for the therapy of coronary heart disease. We're devoted to discovering novel therapeutic approaches that enhance outcomes for patients suffering from underserved coronary heart diseases. Our focus is to know how inflammation and fibrosis contribute to diseases of the guts and to develop therapies, now in clinical trials for uncommon cardiac circumstances, to target these mechanisms and promote healing. A debilitating syndrome attributable to inflammation of the thin fluid-crammed sac surrounding the heart (the pericardium) characterized by sharp and stabbing chest pain, shortness of breath, and fatigue, leading to physical limitations, diminished quality of life, emergency division visits, and hospitalizations. A debilitating syndrome brought on by inflammation of the skinny fluid-stuffed sac surrounding the heart (the pericardium) and is characterized by sharp and stabbing chest pain, shortness of breath, and fatigue, leading to physical limitations, lowered quality of life, emergency division visits, and hospitalizations.


An acute inflammatory disorder of the center muscle (the myocardium) leading to chest ache, impaired coronary heart operate, and heart rhythm irregularities, and is a number one trigger of sudden cardiac death in people below 35 years of age. An acute inflammatory disorder of the heart muscle (the myocardium) leading to chest ache, impaired heart perform, and heart rhythm irregularities, and is a leading cause of sudden cardiac dying in people underneath 35 years of age. A chronic, progressive syndrome in which the center muscle is unable to pump enough blood to meet the body’s needs for blood and oxygen